These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 27562)

  • 1. The indirect assay for leukocyte migration inhibitory factor (LIF)--standardization and the effect of pH.
    Willoughby EW; Dupont B; Hansen JA; Good RA
    J Immunol Methods; 1978; 22(1-2):99-110. PubMed ID: 27562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An indirect assay for canine leukocyte migration inhibitory factor (LIF): demonstration of its species specificity.
    Ansfield MJ; Shalaby MR; Kaltreider HB
    J Immunol Methods; 1980; 34(1):43-8. PubMed ID: 6448271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A method using [3H]leucine-labeled granulocytes or macrophages for migration inhibition assay.
    Sandru G
    J Immunol Methods; 1984 Apr; 69(1):23-32. PubMed ID: 6371141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the human lymphokine leukocyte migration inhibitory factor (LIF) by a sensitive radioenzymatic assay. Inhibitory effect of cGMP on the esterolytic activity of highly purified LIF.
    Bendtzen K
    J Clin Lab Immunol; 1979 Apr; 2(1):37-43. PubMed ID: 95804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin effect on lymphokine production in multiple sclerosis.
    Willoughby EW; Dupont B; Good RA
    Ann Neurol; 1979 Apr; 5(4):391-3. PubMed ID: 375809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of human lymphoid cell line lymphokine preparations (LCL-LK) as working standards in the bioassay of human leucocyte migration inhibition factor (LIF).
    Hamblin AS; Zawisza B; Shipton U; Dumonde DC; Den Hollander FC; Verheul H
    J Immunol Methods; 1982 Nov; 54(3):317-29. PubMed ID: 6757327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial characterization of leukocyte inhibitory factor by concanavalin A-stimulated human lymphocytes (LIF Con A).
    Rocklin RE
    J Immunol; 1975 Apr; 114(4):1161-5. PubMed ID: 1090666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficient lymphokine production of newborn lymphocytes.
    Winter HS; Gard SE; Fischer TJ; Bryson YJ; Stiehm ER
    Pediatr Res; 1983 Jul; 17(7):573-8. PubMed ID: 6225985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro migration inhibition of [3H]leucine-labeled granulocytes by supernatants of Con A-Sepharose stimulated MNC cultures.
    Sandru G; Veraguth P
    Immunol Lett; 1985; 10(3-4):127-32. PubMed ID: 3899921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some physicochemical properties of human leucocyte migration inhibitory factor (LIF).
    Bendtzen K
    Acta Pathol Microbiol Scand C; 1976 Dec; 84C(6):471-6. PubMed ID: 11637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteria induce lymphokine synthesis polyclonally in human B lymphocytes.
    Räsänen L; Karhumäki E; Arvilommi H
    J Immunol; 1978 Aug; 121(2):418-20. PubMed ID: 98583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cell-mediated immunity to tuberculin as assayed by the agarose micro-droplet leukocyte migration inhibition technique: comparison with the capillary tube assay.
    McCoy JL; Dean JH; Herberman RB
    J Immunol Methods; 1977; 15(4):355-71. PubMed ID: 874326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors.
    Bendtzen K
    Scand J Immunol; 1977; 6(1-2):126-31. PubMed ID: 322258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human leukocyte migration inhibitory factor (LIF) III. Further investigations on the serine protease nature of this lymphokine and its preference for arginine amides.
    Bendtzen K
    Scand J Immunol; 1977; 6(10):1055-62. PubMed ID: 335493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-step indirect migration inhibiton (LIF) assay.
    Kalmár L; Gergely P
    J Immunol Methods; 1982 Sep; 53(2):245-50. PubMed ID: 6958754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte inhibitory factor (LIF) production from lymphocytes stimulated by leucogenenol.
    Fumarola D; Jirillo E; De Rinaldis P; Pasquetto N; Monno R; Munno I
    Boll Ist Sieroter Milan; 1977 Mar; 56(2):126-31. PubMed ID: 326269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte inhibiting factor (LIF) production from human lymphocytes stimulated by bacterial lipopolysaccharides.
    Jirillo E; Pasquetto N; Monno RA; De Rinaldis P; Fumarola D; Pantaleo R
    Boll Ist Sieroter Milan; 1976; 55(6):560-7. PubMed ID: 798596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucocyte migration inhibition factor (LIF) production by lymphocytes of normal children, newborns, and children with immune deficiency.
    Hahn T; Levin S; Handzel ZT
    Clin Exp Immunol; 1976 Jun; 24(3):448-54. PubMed ID: 133010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukocyte migration inhibitory factor (LIF). II. Partial biochemical characterization of the substrate specificities for this lymphokine.
    Bendtzen K
    Scand J Immunol; 1977; 6(1-2):133-40. PubMed ID: 322260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.